Siga Technologies: Pay

Siga Technologies paid its 4 named executives $7.9M in total in FY2025 (Dec). CEO Diem Nguyen, Ph.D. MBA was paid $3.2M of that.

Pay$100 in the stock at the end of FY21 → $86
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Diem Nguyen, Ph.D. MBAChief Executive Officer and Director
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years
Daniel J. LuckshireExecutive Vice President and Chief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Dennis E. Hruby, Ph.D.Executive Vice President and Chief Scientific Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Larry MillerGeneral Counsel and Corporate Secretary
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 9 peers with pay on file was $4.3M. The CEO of Siga Technologies was paid $3.2M, 25% below the median.

  1. 1Harmony Biosciences Holdings
  2. 2CorMedix
  3. 3Emergent BioSolutions
  4. 4Rigel Pharmaceuticals
  5. 5UroGen Pharma
  6. 6Vanda Pharmaceuticals
  7. 7Aquestive Therapeutics
  8. 8Siga Technologies
  9. 9Eton Pharmaceuticals
  10. 10Collegium Pharmaceutical
  11. 11Akebia TherapeuticsNot disclosed
  12. 12Esperion Therapeutics, Inc.Not disclosed
  13. 13Fennec Pharmaceuticals, Inc.Not disclosed
  14. 14Heron Therapeutics, Inc.Not disclosed
  15. 15Innoviva Specialty Therapeutics, Inc.Not disclosed
  16. 16Invivyd, Inc.Not disclosed
  17. 17Ironwood Pharmaceuticals, Inc.Not disclosed
  18. 18Ligand PharmaceuticalsNot disclosed
  19. 19Liquidia Technologies Inc.Not disclosed
  20. 20Theravance Biopharma, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.